Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Sean Pitroda

Concepts (261)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Metastasis
23
2021
1046
2.660
Why?
Neoplasms
24
2022
2691
2.010
Why?
Drug Resistance, Neoplasm
3
2021
579
1.540
Why?
Immunotherapy
7
2022
577
1.530
Why?
Mucin-1
9
2020
45
1.480
Why?
Radioimmunotherapy
3
2021
25
1.200
Why?
Carcinoma, Non-Small-Cell Lung
6
2021
983
1.170
Why?
Lung Neoplasms
9
2021
2118
1.090
Why?
Gene Expression Regulation, Neoplastic
13
2020
1209
1.090
Why?
Radiotherapy
3
2020
338
1.020
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2021
102
0.890
Why?
Radiosurgery
6
2021
254
0.870
Why?
Homologous Recombination
2
2017
47
0.800
Why?
Liver Neoplasms
5
2020
634
0.780
Why?
STAT1 Transcription Factor
4
2009
49
0.710
Why?
Gene Amplification
1
2018
134
0.710
Why?
Janus Kinase 2
1
2018
58
0.700
Why?
Pyrrolidines
1
2018
58
0.700
Why?
Neoplasm Invasiveness
1
2019
531
0.700
Why?
Anthracyclines
1
2017
28
0.670
Why?
Colorectal Neoplasms
5
2020
857
0.670
Why?
Neoplasm, Residual
2
2017
132
0.660
Why?
Prostatic Neoplasms
5
2021
1479
0.650
Why?
Sulfonamides
1
2018
328
0.600
Why?
Breast Neoplasms
7
2017
2778
0.580
Why?
Drug Therapy
1
2014
77
0.530
Why?
Radiation Tolerance
3
2019
174
0.520
Why?
DNA Repair
2
2022
351
0.510
Why?
Protein Kinase Inhibitors
1
2018
566
0.510
Why?
Cell Line, Tumor
15
2020
2425
0.510
Why?
Prognosis
10
2021
3704
0.500
Why?
Humans
53
2022
83350
0.490
Why?
Radiation, Ionizing
5
2021
126
0.490
Why?
Combined Modality Therapy
9
2021
1682
0.460
Why?
Neovascularization, Pathologic
1
2012
356
0.410
Why?
Endothelium, Vascular
1
2012
452
0.410
Why?
Gene Expression Profiling
8
2020
1367
0.390
Why?
Metabolic Networks and Pathways
1
2009
72
0.390
Why?
Mutation
2
2018
3861
0.390
Why?
Antibodies, Monoclonal, Humanized
3
2020
940
0.380
Why?
Chemoradiotherapy
3
2021
288
0.380
Why?
Signal Transduction
9
2020
3300
0.370
Why?
MicroRNAs
4
2018
508
0.370
Why?
Animals
26
2021
26976
0.350
Why?
Lipid Metabolism
1
2009
212
0.350
Why?
Energy Metabolism
1
2009
265
0.350
Why?
Gene Regulatory Networks
2
2009
282
0.340
Why?
Chromosomes, Human, Pair 14
2
2018
53
0.330
Why?
Antineoplastic Agents
2
2021
2362
0.330
Why?
Inflammation
1
2012
824
0.330
Why?
Survival Rate
5
2021
1919
0.330
Why?
Mice
16
2021
11129
0.320
Why?
Neoplasms, Experimental
3
2019
284
0.310
Why?
Kaplan-Meier Estimate
4
2018
898
0.310
Why?
Xenograft Model Antitumor Assays
2
2018
463
0.300
Why?
Genomic Instability
2
2017
68
0.300
Why?
Aged
11
2021
18500
0.300
Why?
Mice, Nude
5
2020
785
0.290
Why?
DNA Replication
2
2017
176
0.290
Why?
Emotions
1
2008
304
0.290
Why?
Brain Mapping
1
2008
543
0.290
Why?
Middle Aged
12
2021
25587
0.280
Why?
Cognition
1
2008
498
0.270
Why?
Predictive Value of Tests
1
2009
1756
0.260
Why?
Male
15
2021
41881
0.260
Why?
Aged, 80 and over
5
2021
6576
0.250
Why?
DNA Methylation
2
2018
577
0.250
Why?
Female
16
2021
44762
0.250
Why?
Tumor Necrosis Factor-alpha
3
2012
694
0.240
Why?
Adult
8
2021
25984
0.240
Why?
Interferon Type I
2
2021
181
0.240
Why?
Erythroid Precursor Cells
1
2021
31
0.220
Why?
Butyrates
1
2021
37
0.220
Why?
Cell Proliferation
4
2018
1612
0.220
Why?
Neuroendocrine Tumors
1
2022
89
0.210
Why?
Apoptosis
5
2018
1774
0.210
Why?
Tumor Cells, Cultured
3
2018
1088
0.210
Why?
Disease Progression
3
2020
1470
0.210
Why?
Carcinoma, Neuroendocrine
1
2020
28
0.210
Why?
Adenocarcinoma
3
2016
1195
0.210
Why?
Cell Survival
4
2019
1012
0.200
Why?
Proto-Oncogene Proteins c-myc
2
2020
109
0.200
Why?
Colonic Neoplasms
2
2015
561
0.190
Why?
Neoplasms, Second Primary
1
2021
251
0.190
Why?
Class II Phosphatidylinositol 3-Kinases
1
2018
8
0.190
Why?
Treatment Outcome
7
2021
7895
0.190
Why?
Oligonucleotide Array Sequence Analysis
2
2012
702
0.180
Why?
Follow-Up Studies
3
2021
3877
0.180
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
125
0.180
Why?
Receptor, Notch1
1
2018
81
0.180
Why?
Proto-Oncogene Proteins
1
2022
677
0.180
Why?
Urologic Neoplasms
1
2018
73
0.180
Why?
Brain
1
2008
2159
0.170
Why?
Interferon-beta
2
2016
131
0.170
Why?
Palliative Care
1
2019
254
0.170
Why?
Neuronal Plasticity
1
2020
237
0.170
Why?
Preoperative Period
1
2017
87
0.170
Why?
DNA Breaks, Double-Stranded
1
2017
54
0.170
Why?
DNA Damage
2
2017
357
0.170
Why?
Antimetabolites, Antineoplastic
1
2018
250
0.160
Why?
T-Lymphocytes
2
2021
1288
0.160
Why?
Mice, Inbred C57BL
7
2021
3179
0.160
Why?
Vascular Endothelial Growth Factor A
1
2018
382
0.160
Why?
Pancreatic Neoplasms
1
2022
674
0.160
Why?
Chemokine CXCL10
1
2015
16
0.150
Why?
Proto-Oncogene Proteins p21(ras)
1
2016
143
0.150
Why?
MAP Kinase Kinase Kinases
1
2015
49
0.150
Why?
Prostate
2
2020
260
0.140
Why?
Gene Knockdown Techniques
2
2018
244
0.140
Why?
RNA Helicases
1
2014
35
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2021
2313
0.130
Why?
Antibodies, Monoclonal
1
2021
1524
0.130
Why?
Quality of Life
1
2021
1369
0.130
Why?
Urinary Bladder Neoplasms
1
2016
329
0.130
Why?
DEAD-box RNA Helicases
1
2014
75
0.130
Why?
Hospitalization
1
2018
766
0.120
Why?
Human Umbilical Vein Endothelial Cells
1
2012
61
0.120
Why?
rab GTP-Binding Proteins
1
2012
27
0.120
Why?
Disease Models, Animal
2
2016
2298
0.120
Why?
Endothelial Cells
2
2012
402
0.120
Why?
Transcriptional Activation
2
2012
287
0.120
Why?
Estrogen Receptor alpha
2
2012
136
0.120
Why?
Stress, Physiological
1
2014
247
0.120
Why?
Melanoma, Experimental
2
2009
105
0.110
Why?
Retrospective Studies
2
2021
7634
0.110
Why?
Diagnostic Imaging
1
2015
454
0.110
Why?
Interferon-gamma
4
2019
461
0.110
Why?
Receptors, Estrogen
1
2012
382
0.100
Why?
Glioma
1
2012
314
0.100
Why?
Adaptive Immunity
2
2021
162
0.100
Why?
Multivariate Analysis
1
2012
1011
0.100
Why?
Tandem Mass Spectrometry
1
2009
97
0.100
Why?
X-Ray Therapy
1
2008
6
0.100
Why?
Proteome
1
2009
108
0.090
Why?
Interleukins
1
2009
122
0.090
Why?
Radiation-Sensitizing Agents
1
2008
102
0.090
Why?
Neoplasm Staging
3
2021
1924
0.090
Why?
Magnetic Resonance Imaging
2
2012
3265
0.090
Why?
HCT116 Cells
2
2018
148
0.090
Why?
Neoplasm Transplantation
3
2016
400
0.080
Why?
Cholesterol
1
2009
438
0.080
Why?
Cells, Cultured
1
2012
2969
0.080
Why?
CD8-Positive T-Lymphocytes
1
2010
512
0.080
Why?
Neoplasm Recurrence, Local
1
2012
1185
0.080
Why?
Recurrence
1
2009
1196
0.080
Why?
Mice, Knockout
3
2019
1953
0.080
Why?
Mice, SCID
2
2016
240
0.070
Why?
Neoplasm Proteins
1
2009
547
0.070
Why?
Cell Movement
2
2019
744
0.070
Why?
Mice, Transgenic
2
2019
1553
0.060
Why?
Proportional Hazards Models
2
2016
870
0.060
Why?
Poly(ADP-ribose) Polymerases
1
2022
43
0.060
Why?
Metastasectomy
1
2020
10
0.050
Why?
Myeloid Cells
1
2021
80
0.050
Why?
Vancomycin
1
2021
94
0.050
Why?
Androgen Antagonists
1
2021
122
0.050
Why?
POU Domain Factors
1
2020
6
0.050
Why?
Synaptophysin
1
2020
11
0.050
Why?
Prospective Studies
2
2021
4081
0.050
Why?
Octamer Transcription Factor-3
1
2020
14
0.050
Why?
Antineoplastic Agents, Hormonal
1
2021
153
0.050
Why?
SOXB1 Transcription Factors
1
2020
18
0.050
Why?
Administration, Oral
1
2021
726
0.050
Why?
Kruppel-Like Transcription Factors
1
2020
114
0.050
Why?
Receptors, Tumor Necrosis Factor
2
2009
84
0.050
Why?
Feasibility Studies
1
2021
759
0.050
Why?
Gastrointestinal Tract
1
2021
191
0.050
Why?
Clinical Trials, Phase III as Topic
1
2019
163
0.050
Why?
Neoplastic Stem Cells
1
2020
135
0.050
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2020
161
0.050
Why?
Clinical Trials, Phase II as Topic
1
2019
171
0.050
Why?
Azacitidine
1
2018
122
0.050
Why?
Rats
3
2010
4351
0.050
Why?
Molecular Targeted Therapy
1
2020
273
0.050
Why?
Cell Line
2
2016
2615
0.040
Why?
Dose-Response Relationship, Radiation
1
2018
201
0.040
Why?
Nerve Tissue Proteins
1
2021
529
0.040
Why?
Tumor Suppressor Protein p53
1
2020
369
0.040
Why?
Promoter Regions, Genetic
2
2012
942
0.040
Why?
Comorbidity
1
2021
937
0.040
Why?
cdc25 Phosphatases
1
2016
18
0.040
Why?
Bacteria
1
2021
443
0.040
Why?
Immunity, Innate
1
2021
428
0.040
Why?
Transcriptome
1
2021
513
0.040
Why?
Remission Induction
1
2018
715
0.040
Why?
Radiotherapy Dosage
1
2018
480
0.040
Why?
Epigenesis, Genetic
1
2020
434
0.040
Why?
E1A-Associated p300 Protein
1
2016
10
0.040
Why?
RNA, Small Untranslated
1
2016
12
0.040
Why?
Transcription Factor RelA
1
2016
53
0.040
Why?
Epithelial-Mesenchymal Transition
1
2016
66
0.040
Why?
Medical Oncology
1
2020
331
0.040
Why?
Patient Safety
1
2018
212
0.040
Why?
Phenotype
2
2015
2293
0.040
Why?
Receptors, CXCR3
1
2015
12
0.040
Why?
Homeodomain Proteins
1
2020
546
0.040
Why?
Luminescent Measurements
1
2015
62
0.040
Why?
Wnt Proteins
1
2016
129
0.040
Why?
Immunoprecipitation
1
2015
135
0.040
Why?
Clinical Trials as Topic
1
2020
1199
0.040
Why?
Survival Analysis
1
2019
1583
0.040
Why?
Chromatin Immunoprecipitation
1
2015
133
0.040
Why?
Randomized Controlled Trials as Topic
1
2019
862
0.040
Why?
Mice, Inbred NOD
1
2015
181
0.040
Why?
Immunoblotting
1
2015
279
0.030
Why?
Flow Cytometry
1
2016
725
0.030
Why?
beta Catenin
1
2016
247
0.030
Why?
Tumor Burden
1
2015
287
0.030
Why?
Transcription, Genetic
2
2009
1167
0.030
Why?
Biopsy
1
2018
1180
0.030
Why?
RNA, Small Interfering
1
2016
568
0.030
Why?
HEK293 Cells
1
2016
642
0.030
Why?
Spheroids, Cellular
1
2012
31
0.030
Why?
Polymerase Chain Reaction
1
2015
999
0.030
Why?
Imaging, Three-Dimensional
1
2016
584
0.030
Why?
Peptides
1
2016
639
0.030
Why?
NF-kappa B
1
2015
429
0.030
Why?
Risk Assessment
1
2020
2281
0.030
Why?
Glioblastoma
1
2014
253
0.030
Why?
Estradiol
1
2012
260
0.030
Why?
Salvage Therapy
1
2012
224
0.030
Why?
Neoplasm Grading
1
2012
321
0.030
Why?
Time Factors
1
2020
5496
0.030
Why?
Prostate-Specific Antigen
1
2012
313
0.030
Why?
Gene Expression
1
2015
1331
0.030
Why?
Mammary Glands, Human
1
2009
19
0.030
Why?
Tomography, X-Ray Computed
1
2020
2569
0.030
Why?
Cell Differentiation
1
2016
1474
0.030
Why?
Mice, Mutant Strains
1
2010
252
0.030
Why?
Cytotoxins
1
2009
18
0.020
Why?
Infant
1
2016
3099
0.020
Why?
Interleukin-8
1
2009
84
0.020
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2008
22
0.020
Why?
Coculture Techniques
1
2009
158
0.020
Why?
Prostatectomy
1
2012
431
0.020
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2008
46
0.020
Why?
Caspases
1
2009
169
0.020
Why?
Cytoplasm
1
2009
286
0.020
Why?
Child, Preschool
1
2016
3756
0.020
Why?
Adenoviridae
1
2010
348
0.020
Why?
Doxorubicin
1
2009
296
0.020
Why?
Genetic Vectors
1
2010
449
0.020
Why?
Interleukin-6
1
2009
237
0.020
Why?
Protein Binding
1
2012
1509
0.020
Why?
Patient Selection
1
2012
698
0.020
Why?
Transplantation, Heterologous
1
2009
369
0.020
Why?
Brain Neoplasms
1
2014
807
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
923
0.020
Why?
Protein Structure, Tertiary
1
2009
766
0.020
Why?
Transfection
1
2009
943
0.020
Why?
Lymphocyte Activation
1
2010
806
0.020
Why?
Cell Transformation, Neoplastic
1
2009
410
0.020
Why?
Immunoglobulin G
1
2008
482
0.020
Why?
Disease-Free Survival
1
2009
1196
0.020
Why?
Fibroblasts
1
2009
731
0.020
Why?
Amino Acid Sequence
1
2009
2175
0.020
Why?
Cytokines
1
2009
748
0.020
Why?
Child
1
2016
6759
0.020
Why?
Molecular Sequence Data
1
2009
3194
0.020
Why?
Lung
1
2009
1059
0.020
Why?
Immunosuppressive Agents
1
2008
1026
0.020
Why?
Pitroda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_